

HY-132259 · 1 mg
MedChemExpress · Cat: HY-132259
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/depatuxizumab-mafodotin.htmlDescription
Depatuxizumab mafodotin ABT-414 is an antibody-drug conjugate ADC . Depatuxizumab mafodotin specifically targets the epidermal growth factor receptor EGFR . Depatuxizumab mafodotin can be used in the study of glioma, head and neck squamous cell carcinoma, non-small cell lung cancer, epidermoid carcinoma of the skin, and squamous cell carcinoma of the tongue.







